Protocol No.: VRDN-003-301

Title
A phase 3, randomized, double-masked, placebo-controlled, efficacy, safety, and tolerability study of VRDN-003 in participants with active thyroid eye disease (TED) Reveal 1
Principal Investigator
Nguyen, John
Phase
II/III
Age Group
Adult
Applicable Disease Site
Other
Participating Institutions
Eye Institute
West Virginia University
Contacts
Athena Echols
Clinical Trials Coordinator
Phone: +1 304-598-6977
Christina Sundar, CRC
Clinical Research Coordinator
Phone: +1 304-598-6956
Emalee Taylor
Certified Ophthalmic Assistant